Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

Item
http://www.wikidata.org/entity/Q28565468
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerStaphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts.PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysisEffect of compressive force on the production of prostaglandin E(2) and its receptors in osteoblastic Saos-2 cells.8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblastsBone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors.Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis.9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts.In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss.
P2860

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

Item
http://www.wikidata.org/entity/Q28565468
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
scientific journal article
@en
vedecký článok (publikovaný 2002/01/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
Effects of selective prostagla ...... n and bone resorption in vitro
@ast
Effects of selective prostagla ...... n and bone resorption in vitro
@en
Effects of selective prostagla ...... n and bone resorption in vitro
@nl
type
label
Effects of selective prostagla ...... n and bone resorption in vitro
@ast
Effects of selective prostagla ...... n and bone resorption in vitro
@en
Effects of selective prostagla ...... n and bone resorption in vitro
@nl
prefLabel
Effects of selective prostagla ...... n and bone resorption in vitro
@ast
Effects of selective prostagla ...... n and bone resorption in vitro
@en
Effects of selective prostagla ...... n and bone resorption in vitro
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Effects of selective prostagla ...... n and bone resorption in vitro
@en
P2093
P304
P31
P356
10.1016/S8756-3282(01)00688-3
P433
P478
P577
P698